Lekarze i firmy farmaceutyczne – standardy etyczne wzajemnych relacji w Unii Europejskiej

Marta Makowska

doi:10.18778/1899-2226.15.13

Autor

Marta Makowska Szkoła Główna Gospodarstwa Wiejskiego

DOI:

https://doi.org/10.18778/1899-2226.15.13

Słowa kluczowe:

pharmaceutical companies, physicians, professional ethics

Abstrakt

Within last twenty years in the European Union much regulation concerning advertisements of drugs changed. The aggressive marketing operations of producers of medicines caused that new solutions, not only legal but also ethical, had appeared. The European Union is imposing reliable solutions upon its members in the form of directives to which they must adapt their law. They can however decide to choose stricter law than the one which is recommended to them. The European Federation of Pharmaceutical Industry and Associations – voluntary organization consisting associations of pharmaceutical companies from lots of countries is acting on similar principles. Each of the members belonging to it can implement its own, more restrictive regulation in the national ethical code than a Federation is ordering. Main purpose of this article is reading what legal and ethical solutions of pharmaceutical marketing were accepted in selected countries of the European Union. Whether they are stricter than the ones imposed upon them by European Union? How in this background Polish regulations are looking like? In the article also examples of the law-breaking and ethical principles by producers of medicines in the European Union will be presented. It will show sanctions taken out towards them for this reason. A question will be put: are various penalties able effectively to scare the pharmaceutical industry off the unethical or even unlawful advertising?

Bibliografia

Carpenter G., Italian Doctors Face Charges over GSK Incentive Scheme, „The Lancet” 2004, nr 363.
Google Scholar DOI: https://doi.org/10.1016/S0140-6736(04)16394-0

Dieners P., M. Oeben, Germany [w:] The International Comparative Legal Guide to Pharmaceutical Advertising 2010. A Practical Insight to Cross-border Pharmaceutical Advertising Work, red. Global Legal Group, Global Legal Group, London 2010.
Google Scholar

Drouault-Gardrat P., France [w:] The International Comparative Legal Guide to Pharmaceutical Advertising 2010. A Practical Insight to Cross-border Pharmaceutical Advertising Work, red. Global Legal Group, Global Legal Group, London 2010.
Google Scholar

Dz. U. 2001 nr 126 poz. 1381, Ustawa Prawo farmaceutyczne.
Google Scholar DOI: https://doi.org/10.1055/s-2001-18654

Dz. U. 2008 nr 210 poz. 1327, Rozporządzenie Ministra Zdrowia w sprawie reklamy produktów leczniczych.
Google Scholar

Dz. U. 2008 nr 45 poz. 271, Obwieszczenie Marszałka Sejmu Rzeczypospolitej Polskiej w sprawie ogłoszenia jednolitego tekstu ustawy – Prawo farmaceutyczne.
Google Scholar

Dz.U. L. 113/1992, Dyrektywa 92/28/EEC, W sprawie reklamy produktów leczniczych.
Google Scholar

Dz.U. L. 136/ 2004, Dyrektywa 2004/27/EC, Zmieniająca dyrektywę 2001/83/EC w sprawie wspólnotowego kodeksu odnoszącego się do produktów leczniczych stosowanych u ludzi.
Google Scholar

Dz.U. L. 311/2001, Dyrektywa 2001/83/EC, W sprawie wspólnotowego kodeksu odnoszącego się do produktów leczniczych stosowanych u ludzi.
Google Scholar

EFPIA, About EFPIA, http://www.efpia.org/Content/default.asp?PageID=319
Google Scholar

European Federation of Pharmaceutical Industries and Associations, The Pharmaceutical Industry in Figures, EFPIA 2010.
Google Scholar

Eurostat, Public Health Statistics. Main Tables, http://epp.eurostat.ec.europa.eu/portal/page/portal/health/public_health/data_public_health/main_tables
Google Scholar

Farmindustria, Code of professional conduct Farmindustria 2009, http://www.farmindustria.it/pubblico/02cofain.pdf
Google Scholar

IMS Health, Total Unaudited and Audited Global Pharmaceutical Market by Region, http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Top_Line_Data/Global%20Pharmaceutical%20Market%20By%20Region_April_2009.pdf
Google Scholar

Istituto di Autodisciplina pubblicitare, Codice di Autodisciplina della Comunicazione Commerciale, http://www.iap.it/it/codice.htm
Google Scholar

LEEM, The French Pharmaceutical Companies Association, http://www.leem.org/medicament/version-anglaise-751.htm
Google Scholar

Lizut M., Jak ustawić lekarza, „Gazeta Wyborcza” 2006, nr 120.
Google Scholar

Makowska M., Etyczne wyzwania współpracy pomiędzy lekarzami a przemysłem farmaceutycznym, „Annales. Etyka w życiu gospodarczym” 2011, tom 14, nr 2.
Google Scholar DOI: https://doi.org/10.18778/1899-2226.14.2.06

OECD, Pharmaceutical Pricing Polices in a Global Market, OECD, Paris 2008.
Google Scholar

Orellana C., German Doctors Links with Drug Firm Investigated, „The Lancet” 2002, nr 359.
Google Scholar DOI: https://doi.org/10.1016/S0140-6736(02)08112-6

Villanueva P., S. Peiro, J. Librero, I. Pereiro, Accuracy of Pharmaceutical Advertisements in Medical Journals, „The Lancet” 2003, nr 361.
Google Scholar DOI: https://doi.org/10.1016/S0140-6736(03)12118-6